Six Years and a Forged Prescription: Ruti Aga's Case Shows the Real Verdict in Marathon Is Written in a Medical File

I opened the sheet at midnight and the numbers started talking. In Ruti Aga's file, one date appeared twice — 10 September, once as the start of her provisional suspension, once as the point from which the ban is counted. Between them sit six years. The figure that speaks loudest in this case is not 2:18:34, not 2:20:40, not any split from that March race. It is six.

The Athletics Integrity Unit's decision, released on Thursday, comes in two pieces. That split is the whole story, and it is why this is less a doping report than a medical-governance report.

Aga is not an unknown. She won the 2026 Tokyo Marathon. Second at Berlin 2026, and three World Marathon Majors podium-second finishes in total — the record of a genuine 2:18-2:20 athlete. In the depth chart of Ethiopian women's marathoning she was not the top layer, but she belonged to the layer that keeps landing on major podiums. At 32 she was at the point on the curve where raw speed fades and experience, appearance fees and carefully chosen races take over.

In March she won a half marathon in China. The in-competition sample from that race returned methylprednisolone. A knee injury was cited. And when the paperwork for that treatment was requested, the paperwork got made.

One factual correction first, because a lot of coverage has framed the entire case by calling this a steroid. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, class S9 on the WADA Prohibited List. And S9 is prohibited in-competition only, by injection, oral or rectal route. A therapeutic knee injection given out of competition is entirely legal; it becomes a violation only if residues are present on race day. A road race's testing window opens at 23:59 the night before the start, so an injection given days earlier can still be caught.

This means Aga had a real defence available — route, timing and medical necessity. The AIU statement records the knee injury. Knee synovitis treatment in distance runners works exactly this way. Had the records been genuine, the length of the sanction would have been arguable, and the argument might have landed well below two years.

The records were not genuine. The investigation found three layers. First: the clinic named on the prescription did not exist. Second: the person who wrote it was a family member with no medical registration. Third: that person claimed to have used an old prescription pad from a former workplace, and the clinic flatly disowned the claim.

The decision said one thing, the prescription another, the clinic a third. Three independent verification failures. This is not a filing error — it is a portrait of a system in which a top athlete runs without a credentialed team physician.

The sanction arithmetic follows from that system. Two years for presence of the substance, four for tampering, six in total. The two implies the panel found presence proven but no aggravating intent — the Specified Substance standard. The four implies the tampering was held fully culpable. The real paradox is that forged documentation is itself the most direct evidence of concealment intent, and yet it did not escalate the presence sanction — it was simply placed in a separate box. With genuine documents she had one defence that could have worked. She destroyed it herself.

The ban is backdated to 10 September, meaning the provisional suspension counts against it. That is procedural housekeeping, not a discount — the clock was already running.

Two things the statement does not spell out but standard practice makes clear. The March race result and prize money will almost certainly be annulled, because the AIU's default is to disqualify the competition where the sample was collected. And the 2026 Tokyo title does not automatically fall, because the violation is anchored to a later-year race — although the source does not state the disqualification scope. This is exactly the distinction that disappears from most coverage.

One more detail makes the case unusual: the four-year tampering sanction arises from an interview, not a document alone. That is, from statements made under questioning. Language and translation conditions in AIU interviews have long been a point of contention, and here the sequence repeated itself — a substance violation first, then a second violation manufactured in the explanation of it. A CAS appeal window typically runs about twenty-one days from the reasoned decision, but a document-based forgery finding is hard to overturn.

The economics of the Chinese label circuit sit at the centre of this case. For East African marathoners, the tier between the Majors is a fixed income bracket — decent appearance fees, low risk, a countable number of races. A 2:18-2:20 athlete runs that model. That same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races, and the runners who use that route most heavily tend to have the thinnest precautionary infrastructure around them.

Watching old major footage this week, one pattern was hard to miss. The people standing beside Ethiopian and Kenyan runners in the mixed zone are usually managers, rarely team physicians. A runner with a swollen knee makes a phone call that night, and that call frequently does not reach a credentialed sports physician. The shortcut is not always caught. This time it was.

A question that is not being asked enough: six years for a substance with no proven endurance benefit. Several anabolic cases carry a four-year standard. The comparison yields two readings at once — AIU rigour, and inconsistency in the documentary sanctions that keep landing on African road runners. Choosing one reading means reading half the file.

No statement has emerged from the Ethiopian federation. Only the AIU spoke. In a system where a top athlete does not have a team doctor, the national body should have been asked the question. That question was never written.

Six years at 32 — a return at 38. In the depth of Ethiopian women's marathoning, a 38-year-old returnee with a doping record on her name is effectively unselectable. The ban is six years long; the effect is permanent.

The lesson here lives in document science, not substance science. I added a column to my old sheet this season — investigation paperwork. A runner without a medical file also has no route out of a sanction, and that understanding will save more careers over the next four years than any test.

The question is not who wrote the prescription. The question is who was with that athlete the night she was made to feel that forging a script was easy and finding a doctor was hard.